Gene targeting: Techniques and applications to transplantation

Transplantation

Volumn 64, Issue 9, 1997, Pages 1227-1235

  Porter, Andrew C G ^a   Dallman, Margaret J ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOTRANSPLANTATION; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GRAFT REJECTION; MAMMAL CELL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; XENOGRAFT;

ANIMALS; GENE TARGETING; GRAFT REJECTION; HUMANS; MICE; TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 0030716876     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199711150-00001     Document Type: Review

References (79)

1. Bollag RJ, Waldman AS, Liskay RM. Homologous recombination in mammalian cells. Annu Rev Genet 1989; 23: 199.
2. Capecchi MR. Altering the genome by homologous recombination. Science 1989; 244: 1288.
3. Sedivy JM, Joyner AL. Gene targeting. New York: Freeman, 1992: 184.
4. Joyner AL, ed. Gene targeting. Oxford: IRL Press, 1993: 234.
5. Porter ACG. Gene targeting as an approach to gene therapy. In: Lemoine NR, Cooper DN, eds. Gene therapy. Oxford: BIOS Scientific Publishers, 1996: 169.
6. Thomas KR, Capecchi MR. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987; 51: 503.
7. Shulman MJ, Nissen L, Collins C. Homologous recombination in hybridoma cells: dependence on time and fragment length. Mol Cell Biol 1990; 10: 4466.
8. Smith AJ, Kalogerakis B. Replacement recombinant events targeted at immunoglobulin heavy chain DNA sequences in mouse myeloma cells. J Mol Biol 1990; 213: 415.
9. Deng C, Capecchi MR. Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus. Mol Cell Biol 1992; 12: 3365.
10. te Riele H, Maandag ER, Berns A. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc Natl Acad Sci USA 1992; 89: 5128.
11. van Deursen J, Wieringa B. Targeting of the creatine kinase M gene in embryonic stem cells using isogenic and nonisogenic vectors. Nucleic Acids Res 1992; 20: 3815.
12. Mansour SL, Thomas KR, Capecchi MR. Disruption of the protooncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 1988; 336: 348.
13. Jasin M, Berg P. Homologous integration in mammalian cells without target gene selection. Genes Dev 1988; 2: 1353.
14. Dorin JR, Inglis JD, Porteous DJ. Selection for precise chromosomal targeting of a dominant marker by homologous recombination. Science 1989; 243: 1357.
15. Sedivy JM, Sharp PA. Positive genetic selection for gene disruption in mammalian cells by homologous recombination. Proc Natl Acad Sci USA 1989; 86: 227.
16. Charron J, Malynn BA, Robertson EJ, Goff SP, Alt FW. High-frequency disruption of the N-myc gene in embryonic stem and pre-B cell lines by homologous recombination. Mol Cell Biol 1990; 10: 1799.
17. Itzhaki JE, Porter AC. Targeted disruption of a human interferon-inducible gene detected by secretion of human growth hormone. Nucleic Acids Res 1991; 19: 3835.
18. Mountford P, Zevnik B, Duwel A, et al. Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc Natl Acad Sci USA 1994; 91: 4303.
19. Smith AJ, Berg P. Homologous recombination between defective neo genes in mouse 3T6 cells. Cold Spring Harbor Symp Quant Biol 1984; 49: 171.
20. Lin FL, Sperle K, Sternberg N. Recombination in mouse L cells between DNA introduced into cells and homologous chromosomal sequences. Proc Natl Acad Sci USA 1985; 82: 1391.
21. Brandon EP, Idzerda RL, McKnight GS. Targeting the mouse genome: a compendium of knockouts (part II). Curr Biol 1995; 5: 758.
22. Brandon EP, Idzerda RL, McKnight GS. Targeting the mouse genome: a compendium of knockouts (part III). Curr Biol 1995; 5: 873.
23. Brandon EP, Idzerda RL, McKnight GS. Knockouts. Targeting the mouse genome: a compendium of knockouts (part I). Curr Biol 1995; 5: 625.
24. Takeda S, Masteller EL, Thompson CB, Buerstedde JM. RAG-2 expression is not essential for chicken immunoglobulin gene conversion. Proc Natl Acad Sci USA 1992; 89: 4023.
25. Porter AC, Itzhaki JE. Gene targeting in human somatic cells: complete inactivation of an interferon-inducible gene. Eur J Biochem 1993; 218: 273.
26. Waldman T, Kinzler KW, Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 1995; 55: 5187.
27. Olson EN, Arnold H-H, Rigby PWJ, Wold BJ. Know your neighbours: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 1996; 85: 1.
28. Askew GR, Doetschman T, Lingrel JB. Site-directed point mutations in embryonic stem cells: a gene-targeting tag- and-exchange strategy. Mol Cell Biol 1993; 13: 4115.
29. Valancius V, Smithies O. Testing an "in-out" targeting procedure for making subtle genomic modifications in mouse embryonic stem cells. Mol Cell Biol 1991; 11: 1402.
30. Hasty P, Ramirez Solis R, Krumlauf R, Bradley A. Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature 1991; 350: 243.
31. Baubonis W, Sauer B. Genomic targeting with purified Cre recombinase. Nucleic Acids Res 1993; 21: 2025.
32. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 1994; 265: 103.
33. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science 1995; 269: 1427.
34. Schilham MW, Fung-Leung W-P, Rahemtulla A, et al. Alloreactive cytotoxic T cells can develop and function in mice lacking both CD4 and CD8. Eur J Immunol 1993; 23: 1299.
35. Rajewsky K, Gu H, Kuhn R, et al. Conditional gene targeting. J Clin Invest 1996; 98: 600.
36. Itzhaki JE, Gilbert CS, Porter ACG. Construction by gene targeting in human cells of a "conditional" CDC2 mutant that rereplicates its DNA. Nature Genet 1997; 15: 258.
37. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766.
38. Itzhaki JE, Barnett MA, MacCarthy AB, Buckle VJ, Brown WR, Porter AC. Targeted breakage of a human chromosome mediated by cloned human telomeric DNA. Nat Genet 1992; 2: 283.
39. Ramirez Solis R, Liu P, Bradley A. Chromosome engineering in mice. Nature 1995; 378: 720.
40. Smith AJ, De Sousa MA, Kwabi Addo B, Heppell Parton A, Impey H, Rabbitts P. A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination. Nat Genet 1995; 9: 376.
41. Auchincloss H, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 1993; 90: 3373.
42. Dierich A, Chan SH, Benoist C, Mathis D. Graft rejection by T cells not restricted by conventional major histocompatibility complex molecules. Eur J Immunol 1993; 23: 2725.
43. Li X, Faustman D. Use of donor beta 2-microglobulin-deficient transgenic mouse liver cells for isografts, allografts and xenografts. Transplantation 1993; 55: 940.
44. Henretta J, Araneda D, Pittman K, Thomas F. Marked prolongation of incompatible class I deficient heart allografts: paradoxical effects between primarily and secondarily vascularized allografts. Transplant Proc 1995; 27: 1303.
45. Mannon RB, Nataraj C, Kotzin BL, et al. Rejection of kidney allografts by MHC class I-deficient mice. Transplantation 1995; 59: 746.
46. Markmann JF, Bassiri H, Desai NM, et al. Indefinite survival of MHC class I-deficient murine pancreatic islet allografts. Transplantation 1992; 54: 1085.
47. Campos L, Naji A, Deli BC, et al. Survival of MHC-deficient mouse heterotopic cardiac allografts. Transplantation 1995; 59: 187.
48. Osorio RW, Ascher NL, Jaenisch R, Freise CE, Roberts JP, Stock PG. Major histocompatibility complex class 1 deficiency prolongs islet allograft survival. Diabetes 1993; 42: 1520.
49. Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss H Jr. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med 1994; 179: 865.
50. + cytotoxic T lymphocyte that mediate specific tumor rejection. J Immunol 1993; 151: 6283.
51. + cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class 1-deficient mice in response to immunization with tumor cells. J Immunol 1994; 1994; 152.
52. + cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class 1-deficient mice in response to immunization with tumor cells. J Immunol 1994; 1994; 152.
53. -/- mice are sufficient to mediate rejection of MHC class II or class I disparate skin grafts. J Immunol 1996; 156: 41114.
54. Dalloul AH, Ngo K, Fung-Leung W-P. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice. Bur J Immunol 1996; 26: 213.
55. + cells are essential for allorejection. J Exp Med 1996; 184: 2013.
56. Walsh CM, Hayashi F, Saffron DC, Ju S-T, Berke G, Clark WR. Cell-mediated cytotoxicity results from, but may not be critical for, primary allograft rejection. J Immunol 1996; 156: 1436.
57. Selvaggi G, Ricordi C, Podack ER, Inverardi L. The role of the perform and Fas pathways of cytotoxicity in skin graft rejection. Transplantation 1996; 62: 1912.
58. Schulz M, Schuurman H-J, Joergensen J, et al. Acute rejection of vascular heart allografts by perforin-deficient mice. Eur J Immunol 1995; 25: 474.
59. Wilson RW, Ballantyne CM, Smith CW, et al. Gene targeting yields a CD18-mutant mouse for study of inflammation. J Immunol 1993; 151: 1571.
60. Dallman MJ. Cytokines and transplantation: Th1/Th2 regulation of the immune response to solid organ transplants in the adult. Curr Opin Immunol 1995; 7: 632.
61. Strom TB, Roy-Chaudhury P, Manfro R, et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 1996; 8: 688.
62. Steiger J, Nickerson PW, Steurer W, Moscovitch-Lopatin M, Strom TB. IL-2 knockout recipient mice reject islet cell allografts. J Immunol 1995; 155: 489.
63. Saleem S, Konieczny BT, Lowry RP, Baddoura FK, Lakkis F. Acute rejection of vascularized heart allografts in the absence of IFNγ. Transplantation 1996; 62: 1908.
64. Nickerson P, Zheng XX, Steiger J, et al. Prolonged islet allograft acceptance in the absence of interleukin 4 expression. Transplant Immunol 1996; 4: 81.
65. Lakkis FG, Konieczny BT, Saleem S, et al. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. J Immunol 1997; 158: 2443.
66. White D, Wallwork J. Xenografting: probability, possibility or pipe dream? Lancet 1993; 342: 879.
67. Platt JL. A perspective on xenograft rejection and accommodation. Immunol Rev 1994; 141: 127.
68. Heckl Ostreicher B, Binder R, Kirschfink M. Functional activity of the membrane-associated complement inhibitor CD59 in a pig-to-human in vitro model for hyperacute xenograft rejection. Clin Exp Immunol 1995; 102: 589.
69. Pohlein C, Pascher A, Storck M, et al. The function of transgenic human DAF-expressing porcine livers during hemoperfusion with human blood. Transpl Int 1996; 9: 0934.
70. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells [see comments]. Nature 1997; 385: 810.
71. Lawson JH, Platt JL. Molecular barriers to xenotransplantation. Transplantation 1996; 62: 303.
72. Tearle RG, Tange MJ, Zannettino ZL, et al. The alpha-1,3-galactosyltransferase knockout mouse: implications for xeno-transplantation. Transplantation 1996; 61: 13.
73. Thall AD, Murphy HS, Lowe JB. Alpha 1,3-galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies. Transplant Proc 1996; 28: 556.
74. Blaese RM, Culver KW, Miller AD, et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995; 270: 475.
75. Brenner MK, Cunningham JM, Sorrentino BP, Heslop HE. Gene transfer into human hemopoietic progenitor cells. Br Med Bull 1995; 51: 167.
76. Knechtle SJ, Zhai Y, Fechner J. Gene therapy in transplantation. Transplant Immunol 1996; 4: 257.
77. Vega MA. Prospects for homologous recombination in human gene therapy. Hum Genet 1991; 87: 245.
78. Arbones ML, Austin HA, Capon DJ, Greenburg G. Gene targeting in normal somatic cells: inactivation of the interferon-gamma receptor in myoblasts. Nat Genet 1994; 6: 90.
79. Vilquin J-T, Wagner E, Kinoshita I, Roy R, Tremblay JP. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J Cell Biol 1995; 131: 975.